145 related articles for article (PubMed ID: 21393158)
21. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.
Bagattini M; Crivaro V; Di Popolo A; Gentile F; Scarcella A; Triassi M; Villari P; Zarrilli R
J Antimicrob Chemother; 2006 May; 57(5):979-82. PubMed ID: 16531430
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.
Ahmad S; Al-Juaid NF; Alenzi FQ; Mattar EH; Bakheet Oel-S
J Coll Physicians Surg Pak; 2009 Apr; 19(4):264-5. PubMed ID: 19356348
[TBL] [Abstract][Full Text] [Related]
23. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
[TBL] [Abstract][Full Text] [Related]
24. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Shah PM
Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
[No Abstract] [Full Text] [Related]
25. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Labombardi VJ; Rojtman A; Tran K
Diagn Microbiol Infect Dis; 2006 Nov; 56(3):313-5. PubMed ID: 17084784
[TBL] [Abstract][Full Text] [Related]
26. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
Basak S; Mallick SK; Bose S
J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
[TBL] [Abstract][Full Text] [Related]
27. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece).
Maltezou HC; Giakkoupi P; Maragos A; Bolikas M; Raftopoulos V; Papahatzaki H; Vrouhos G; Liakou V; Vatopoulos AC
J Infect; 2009 Mar; 58(3):213-9. PubMed ID: 19246099
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
29. Outbreak of Klebsiella pneumoniae producing KPC-2 and SHV-12 in a French hospital.
Kassis-Chikhani N; Decré D; Ichai P; Sengelin C; Geneste D; Mihaila L; Dussaix E; Arlet G
J Antimicrob Chemother; 2010 Jul; 65(7):1539-40. PubMed ID: 20460399
[No Abstract] [Full Text] [Related]
30. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
[No Abstract] [Full Text] [Related]
31. The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation.
Calbo E; Garau J
Future Microbiol; 2015; 10(6):1063-75. PubMed ID: 26059626
[TBL] [Abstract][Full Text] [Related]
32. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Lee SO; Lee ES; Park SY; Kim SY; Seo YH; Cho YK
Infect Control Hosp Epidemiol; 2004 Oct; 25(10):832-7. PubMed ID: 15518024
[TBL] [Abstract][Full Text] [Related]
33. Extended Spectrum Beta-Lactamase-producing Klebsiella pneumoniae outbreaks during a third generation cephalosporin restriction policy.
Conte MP; Venditti M; Chiarini F; D'Ettorre G; Zamboni I; Scoarughi GL; Gallinelli C; Orsi GB
J Chemother; 2005 Feb; 17(1):66-73. PubMed ID: 15828446
[TBL] [Abstract][Full Text] [Related]
34. Using active microbiologic surveillance and enhanced infection control measures to control an outbreak of health care-associated extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infections--New Jersey, 2007.
Langer AJ; Lafaro P; Genese CA; McDonough P; Nahass R; Robertson C
Am J Infect Control; 2009 Feb; 37(1):73-5. PubMed ID: 18834744
[TBL] [Abstract][Full Text] [Related]
35. First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011.
O'Brien DJ; Wrenn C; Roche C; Rose L; Fenelon C; Flynn A; Murphy V; FitzGerald SF; Fenelon LE; Crowley B; Schaffer K
Euro Surveill; 2011 Jul; 16(29):. PubMed ID: 21801694
[TBL] [Abstract][Full Text] [Related]
36. Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Marra AR; Pereira CA; Castelo A; do Carmo Filho JR; Cal RG; Sader HS; Wey SB
Int J Infect Dis; 2006 Jan; 10(1):56-60. PubMed ID: 16326126
[TBL] [Abstract][Full Text] [Related]
37. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study.
Behar PR; Teixeira PJ; Fachel JM; Kalil AC
J Hosp Infect; 2008 Feb; 68(2):123-9. PubMed ID: 18192077
[TBL] [Abstract][Full Text] [Related]
38. [Molecular characterization of an outbreak caused by CTX-M-12-producing Klebsiella pneumoniae in a Colombian hospital's neonatal intensive care unit].
Mantilla JR; Reguero MT; González EB; García IA; Leal AL; Espinal PA; Alpuche C; Valderrama IA; Garzón MI; Olarte NM
Biomedica; 2006 Sep; 26(3):408-14. PubMed ID: 17176004
[TBL] [Abstract][Full Text] [Related]
39. Extended spectrum beta lactamase producing gram negative bacilli in a tertiary referral hospital of Assam--experience with two methods.
Nath R; Saikia L; Mahanta J
Indian J Pathol Microbiol; 2006 Oct; 49(4):623-5. PubMed ID: 17183880
[TBL] [Abstract][Full Text] [Related]
40. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains.
Urbánek K; Kolár M; Lovecková Y; Strojil J; Santavá L
J Clin Pharm Ther; 2007 Aug; 32(4):403-8. PubMed ID: 17635342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
